Published in Am J Pathol on October 01, 1993
A serum response factor-dependent transcriptional regulatory program identifies distinct smooth muscle cell sublineages. Mol Cell Biol (1997) 2.20
Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension. Am J Pathol (1997) 1.22
Endothelial dysfunction in the apolipoprotein E-deficient mouse: insights into the influence of diet, gender and aging. Lipids Health Dis (2011) 1.22
Dominant negative murine serum response factor: alternative splicing within the activation domain inhibits transactivation of serum response factor binding targets. Mol Cell Biol (1999) 1.17
The viral anti-inflammatory chemokine-binding protein M-T7 reduces intimal hyperplasia after vascular injury. J Clin Invest (2000) 1.12
Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to endothelium in vivo. Proc Natl Acad Sci U S A (1994) 1.06
Endothelial constitutive nitric oxide synthase protein and mRNA increased in rabbit atherosclerotic aorta despite impaired endothelium-dependent vascular relaxation. Am J Pathol (1996) 0.96
Human immunodeficiency virus-associated vasculopathy in transgenic mice. J Virol (1997) 0.96
Mononuclear cell therapy attenuates atherosclerosis in apoE KO mice. Lipids Health Dis (2011) 0.92
Possible Therapeutic Effect of Stem Cell in Atherosclerosis in Albino Rats. A Histological and Immunohistochemical Study. Int J Stem Cells (2015) 0.91
Aortic endothelial cells regulate proliferation of human monocytes in vitro via a mechanism synergistic with macrophage colony-stimulating factor. Convergence at the cyclin E/p27(Kip1) regulatory checkpoint. J Clin Invest (1997) 0.91
The role of vascular injury and hemodynamics in rat pulmonary artery remodeling. J Clin Invest (1996) 0.91
DNA damage and repair in atherosclerosis: current insights and future perspectives. Int J Mol Sci (2012) 0.90
PDE1 isozymes, key regulators of pathological vascular remodeling. Curr Opin Pharmacol (2011) 0.90
Induction of cyclooxygenase-2 in human umbilical vein endothelial cells by lysophosphatidylcholine. J Clin Invest (1995) 0.89
Expression of the histamine H1 receptor gene in relation to atherosclerosis. Am J Pathol (1995) 0.89
Chronic alcohol feeding inhibits atherogenesis in C57BL/6 hyperlipidemic mice. Am J Pathol (1995) 0.87
Distinct profiles of endothelial gene expression in hyperpermeable regions of the porcine aortic arch and thoracic aorta. Atherosclerosis (2007) 0.85
Extension of the mitochondria dysfunction hypothesis of metabolic syndrome to atherosclerosis with emphasis on the endocrine-disrupting chemicals and biophysical laws. J Diabetes Investig (2013) 0.84
Role of platelet-derived growth factor in allograft vasculopathy. Ann Surg (2000) 0.82
Platelet factor 4 modulates the mitogenic activity of basic fibroblast growth factor. J Clin Invest (1994) 0.80
Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts. Ann Transplant (1997) 0.79
A Simple, Reproducible Animal Model of Arterial Occlusion with Mixed Thrombus. J Thromb Thrombolysis (1996) 0.78
Adhesion receptors of the immune system. Nature (1990) 28.86
The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (1993) 27.07
Vascular endothelial growth factor is a secreted angiogenic mitogen. Science (1989) 16.71
The pathogenesis of atherosclerosis--an update. N Engl J Med (1986) 14.59
Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem (1986) 10.00
Tumor necrosis factor (TNF). Science (1985) 8.80
Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun (1989) 7.39
Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature (1985) 7.22
The biology of platelet-derived growth factor. Cell (1986) 7.17
Role of endothelium in responses of vascular smooth muscle. Circ Res (1983) 7.03
Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med (1990) 6.43
The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med (1992) 6.41
Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science (1973) 6.38
Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med (1986) 6.32
The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem (1989) 5.98
Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science (1991) 5.76
The pathogenesis of atherosclerosis (second of two parts). N Engl J Med (1976) 5.48
Vitamin E consumption and the risk of coronary disease in women. N Engl J Med (1993) 5.39
Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol (1987) 5.25
Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis (1986) 5.23
Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1. J Exp Med (1986) 5.17
A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science (1991) 5.14
Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med (1984) 5.02
Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A (1991) 4.56
Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol (1986) 4.51
Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. Proc Natl Acad Sci U S A (1981) 4.50
Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis (1984) 4.40
Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci U S A (1990) 4.34
TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights. Cell (1990) 4.28
Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci U S A (1987) 4.10
Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol (1989) 3.82
Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science (1988) 3.72
Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest (1990) 3.40
Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci U S A (1987) 3.32
Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today (1990) 3.31
Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science (1990) 3.27
The role of the monocyte in atherogenesis: II. Migration of foam cells from atherosclerotic lesions. Am J Pathol (1981) 3.26
Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-beta. J Biol Chem (1987) 3.25
Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity. Proc Natl Acad Sci U S A (1986) 3.04
Dietary induced atherogenesis in swine. Morphology of the intima in prelesion stages. Am J Pathol (1979) 3.04
Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest (1991) 3.00
Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science (1989) 2.98
The macrophage colony-stimulating factor, CSF-1. Methods Enzymol (1985) 2.91
Cell proliferation in human coronary arteries. Proc Natl Acad Sci U S A (1990) 2.90
Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci U S A (1988) 2.83
TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell (1990) 2.82
Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA (1990) 2.78
Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest (1991) 2.76
Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis (1990) 2.70
The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest (1988) 2.68
Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. Science (1986) 2.67
Tumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin. J Biol Chem (1990) 2.37
Platelet-derived growth factor: mechanism of action and possible in vivo function. Cell Regul (1990) 2.31
Membrane proteins involved in phagocyte adherence to endothelium. Immunol Rev (1990) 2.30
Immunocytochemical analysis of cellular components in atherosclerotic lesions. Use of monoclonal antibodies with the Watanabe and fat-fed rabbit. Arteriosclerosis (1986) 2.27
Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc Natl Acad Sci U S A (1990) 2.23
Inducible interleukin-1 gene expression in human vascular smooth muscle cells. J Clin Invest (1986) 2.21
Polypeptide growth factors: roles in normal and abnormal cell growth. Annu Rev Cell Biol (1987) 2.19
Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J Clin Invest (1985) 2.16
Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol (1992) 2.12
Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic. J Leukoc Biol (1985) 2.11
High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules. Proc Natl Acad Sci U S A (1985) 2.11
T lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis. Am J Pathol (1988) 2.07
Isolation and characterization of a macrophage-derived heparin-binding growth factor. Cell Regul (1990) 1.96
Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration. Mol Cell Biol (1986) 1.94
George Lyman Duff Memorial Lecture. Atherosclerosis: a problem of the biology of arterial wall cells and their interactions with blood components. Arteriosclerosis (1982) 1.90
Role of oxidatively modified LDL in atherosclerosis. Free Radic Biol Med (1990) 1.89
Studies of hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque. Arteriosclerosis (1984) 1.88
Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response. Am J Pathol (1990) 1.88
Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. Am J Pathol (1989) 1.87
Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells. Am J Pathol (1991) 1.82
Production of platelet-derived growth factor-like mitogen by smooth-muscle cells from human atheroma. N Engl J Med (1988) 1.79
Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts. J Clin Invest (1991) 1.79
Immune mechanisms in atherosclerosis. Arteriosclerosis (1989) 1.78
Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest (1989) 1.74
Atherosclerosis in relation to the structure and function of the arterial intima, with special reference to th endothelium. Int Rev Exp Pathol (1966) 1.64
Fatty streak initiation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis (1987) 1.63
Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis. Am J Pathol (1991) 1.59
Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis (1990) 1.58
Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells. Arterioscler Thromb (1991) 1.57
Monocyte chemotactic factor produced by large vessel endothelial cells in vitro. Arteriosclerosis (1986) 1.54
Immunology of atherosclerosis: cellular composition and major histocompatibility complex class II antigen expression in aortic intima, fatty streaks, and atherosclerotic plaques in young and aged human specimens. Clin Immunol Immunopathol (1990) 1.49
An immunohistochemical analysis of human aortic fatty streaks. Hum Pathol (1987) 1.45
Biological and biochemical properties of fibroblast growth factors. Implications for the pathogenesis of atherosclerosis. Arteriosclerosis (1989) 1.45
Prelesional events in atherogenesis. Accumulation of extracellular cholesterol-rich liposomes in the arterial intima and cardiac valves of the hyperlipidemic rabbit. Am J Pathol (1986) 1.45
Control of monocyte recruitment by chemotactic factor(s) in lesion-prone areas of swine aorta. Arteriosclerosis (1985) 1.42
Thromboregulation: multicellular modulation of platelet reactivity in hemostasis and thrombosis. FASEB J (1993) 1.40
Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arterioscler Thromb (1991) 1.39
Focal and segmental glomerulosclerosis: analogies to atherosclerosis. Kidney Int (1988) 1.39
Endothelium-derived relaxing and contracting factors. J Cell Biochem (1991) 1.35
Induction of insulin-like growth factor I messenger RNA in rat aorta after balloon denudation. Circ Res (1990) 1.32
Control of hypertrophic versus hyperplastic growth of vascular smooth muscle cells. Am J Physiol (1989) 1.25
Warner-Lambert/Parke-Davis Award Lecture. Viral pathogenesis of atherosclerosis. Impact of molecular mimicry and viral genes. Am J Pathol (1991) 1.19
Aortic smooth muscle cells express and secrete vascular endothelial growth factor. Growth Factors (1991) 1.19
Morphology of the endothelium over atherosclerotic plaques in human coronary arteries. Br Heart J (1988) 1.14
Topographic study of sudanophilic lesions in cholesterol-fed minipigs by image analysis. Arteriosclerosis (1985) 1.13
Cell constitution and characteristics of human atherosclerotic plaques selectively removed by percutaneous atherectomy. Atherosclerosis (1989) 1.12
Atherogenesis during low level hypercholesterolemia in the nonhuman primate. I. Fatty streak formation. Arteriosclerosis (1990) 1.08